Mucin 13 (MUC13) as a candidate biomarker for ovarian cancer detection: potential to complement CA125 in detecting non-serous subtypes.
Saved in:
| Title: | Mucin 13 (MUC13) as a candidate biomarker for ovarian cancer detection: potential to complement CA125 in detecting non-serous subtypes. |
|---|---|
| Authors: | Ren AH; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada., Filippou PS; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.; Department of Clinical Biochemistry, University Health Network, Toronto, ON, Canada., Soosaipillai A; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada., Dimitrakopoulos L; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada., Korbakis D; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada., Leung F; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.; Department of Clinical Biochemistry, University Health Network, Toronto, ON, Canada., Kulasingam V; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.; Department of Clinical Biochemistry, University Health Network, Toronto, ON, Canada., Bernardini MQ; Division of Gynecologic Oncology, University Health Network, Toronto, ON, Canada., Diamandis EP; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.; Department of Clinical Biochemistry, University Health Network, Toronto, ON, Canada.; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada. |
| Source: | Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2022 Nov 17; Vol. 61 (3), pp. 464-472. Date of Electronic Publication: 2022 Nov 17 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Walter De Gruyter Country of Publication: Germany NLM ID: 9806306 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1437-4331 (Electronic) Linking ISSN: 14346621 NLM ISO Abbreviation: Clin Chem Lab Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1437-4331 |
|---|---|
| DOI: | 10.1515/cclm-2022-0491 |
